Smith Group Asset Management, LLC Collegium Pharmaceutical, Inc Transaction History
Smith Group Asset Management, LLC
- $1.21 Trillion
- Q3 2024
A detailed history of Smith Group Asset Management, LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Smith Group Asset Management, LLC holds 18,824 shares of COLL stock, worth $629,851. This represents 0.06% of its overall portfolio holdings.
Number of Shares
18,824
Previous 15,050
25.08%
Holding current value
$629,851
Previous $485 Million
50.09%
% of portfolio
0.06%
Previous 0.04%
Shares
6 transactions
Others Institutions Holding COLL
# of Institutions
250Shares Held
36.7MCall Options Held
100KPut Options Held
21.1K-
Black Rock Inc. New York, NY5.79MShares$194 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$88.2 Million1.79% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.59MShares$86.6 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.35MShares$78.5 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.66MShares$55.4 Million0.1% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.14B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...